Green Cross Holdings Corp
005257
Company Profile
Business description
Green Cross Holdings Corp manufactures and sells medicines and medical supplies. The company's products include Plasma Derivatives, Vaccines, Prescription Drugs and Over-the-counter Drugs. Some of the drugs offered by the company comprise of Acustop Cataplasma, Zenol Cool Type, Green-VIII inj and Hunterase.
Contact
107 , Ihyeon-ro
30beon-gil, Giheung-gu
Gyeonggi-do
Yongin-si,16924
KORT: +82 312609300
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
150
Stocks News & Analysis
stocks
Are declining Chinese births a red flag for A2 Milk?
Demographic challenges in A2’s largest market lead to sell-off.
stocks
Is this ASX share a value trap or bargain?
Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks
Goldman Sachs Earnings: Valuations remain stretched
We raise our fair value estimate for Goldman Sachs stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,108.60 | 16.20 | 0.18% |
| CAC 40 | 8,062.58 | 49.44 | -0.61% |
| DAX 40 | 24,703.12 | 255.94 | -1.03% |
| Dow JONES (US) | 48,488.59 | 870.74 | -1.76% |
| FTSE 100 | 10,126.78 | 68.57 | -0.67% |
| HKSE | 26,482.59 | 4.92 | -0.02% |
| NASDAQ | 22,954.32 | 561.07 | -2.39% |
| Nikkei 225 | 52,715.81 | 275.29 | -0.52% |
| NZX 50 Index | 13,417.17 | 156.76 | -1.15% |
| S&P 500 | 6,796.86 | 143.15 | -2.06% |
| S&P/ASX 200 | 8,782.90 | 14.00 | 0.16% |
| SSE Composite Index | 4,127.51 | 13.87 | 0.34% |